memantine has been researched along with Sepsis in 3 studies
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Memantine was administrated through gavage at 5, 10, and 20 mg/kg three days before sepsis and continued for three days after sepsis induction." | 8.31 | Memantine, an NMDA receptor antagonist, protected the brain against the long-term consequences of sepsis in mice. ( Arabi, MH; Bardaghi, Z; Beheshti, F; Hosseini, M; Rajabian, A; Salmani, H, 2023) |
| " Memantine, an N-methyl-D-aspartic acid receptor (NMDAR) antagonist, is able to alleviate acute lung injury (ALI)." | 8.12 | Memantine nitrate MN-08 suppresses NLRP3 inflammasome activation to protect against sepsis-induced acute lung injury in mice. ( Hu, H; Jiang, H; Sun, Y; Wang, Y; Yi, P; Zhang, G; Zhang, K; Zhang, Z, 2022) |
| " Memantine was administrated through gavage at 5, 10, and 20 mg/kg three days before sepsis and continued for three days after sepsis induction." | 4.31 | Memantine, an NMDA receptor antagonist, protected the brain against the long-term consequences of sepsis in mice. ( Arabi, MH; Bardaghi, Z; Beheshti, F; Hosseini, M; Rajabian, A; Salmani, H, 2023) |
| " Memantine, an N-methyl-D-aspartic acid receptor (NMDAR) antagonist, is able to alleviate acute lung injury (ALI)." | 4.12 | Memantine nitrate MN-08 suppresses NLRP3 inflammasome activation to protect against sepsis-induced acute lung injury in mice. ( Hu, H; Jiang, H; Sun, Y; Wang, Y; Yi, P; Zhang, G; Zhang, K; Zhang, Z, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, H | 1 |
| Jiang, H | 1 |
| Zhang, K | 1 |
| Zhang, Z | 1 |
| Wang, Y | 1 |
| Yi, P | 1 |
| Zhang, G | 1 |
| Sun, Y | 1 |
| Bardaghi, Z | 1 |
| Rajabian, A | 1 |
| Beheshti, F | 1 |
| Arabi, MH | 1 |
| Hosseini, M | 1 |
| Salmani, H | 1 |
| Du, F | 1 |
| Sun, W | 1 |
| Morisseau, C | 1 |
| Hammock, BD | 1 |
| Bao, X | 1 |
| Liu, Q | 1 |
| Wang, C | 1 |
| Zhang, T | 1 |
| Yang, H | 1 |
| Zhou, J | 1 |
| Xiao, W | 1 |
| Liu, Z | 1 |
| Chen, G | 1 |
3 other studies available for memantine and Sepsis
| Article | Year |
|---|---|
Memantine nitrate MN-08 suppresses NLRP3 inflammasome activation to protect against sepsis-induced acute lung injury in mice.
Topics: Acute Lung Injury; Animals; Inflammasomes; Lipopolysaccharides; Lung; Memantine; Mice; Mice, Inbred | 2022 |
Memantine, an NMDA receptor antagonist, protected the brain against the long-term consequences of sepsis in mice.
Topics: Acetylcholinesterase; Animals; Brain; Male; Memantine; Mice; NF-kappa B; Receptors, N-Methyl-D-Aspar | 2023 |
Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.
Topics: Animals; Binding Sites; Catalytic Domain; Disease Models, Animal; Drug Design; Enzyme Inhibitors; Ep | 2021 |